Figure 7J–M show the results of the expression validation of four lncRNAs in a cohort of 15 patients (normal tissues:15, paracancerous tissues: 15) with COAD at our hospital, which showed that ZEB1-AS1, SNHG16, and ALMS1-IT1 were expressed at higher levels in tumor samples than those in the corresponding paracancerous samples (p < 0.05), whereas SATB2-AS1 was upregulated in the paracancerous samples (p < 0.05). Here, ALMS1 is linked to neoplasm.